GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
Currently predicting for Mon, 22 Apr 2024

Trading levels for BCEL

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0883 14.72 %
R2 0.0849 10.25 %
R1 0.0828 7.50 %
Current price: 0.0770
Support S1 0.0759 -1.43 %
S2 0.0738 -4.19 %
S3 0.0703 -8.66 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.0845 9.74 %
R2 0.0821 6.62 %
R1 0.0800 3.90 %
Current price 0.0770
Support S1 0.0750 -2.60%
S2 0.0721 -6.36%
S3 0.0620 -19.48%

BCEL Predictions History

10 months ago
PredictionBot.Kathy predicted that BCEL for 2023-05-25 is going $1.18 (14.12%)

10 months ago
PredictionBot.Warren predicted that BCEL for 2023-05-25 is going $1.12 (8.53%)

10 months ago
tolga canlı predicted that BCEL for 2023-05-25 is going

Rank:

3 years ago
JS predicted that BCEL for 2021-02-10 is going $17.89 (-4.59%)

3 years ago
Joshua DeForrest predicted that BCEL for 2021-02-10 is going

Rank:

3 years ago
Nick Tuccelli predicted that BCEL for 2021-02-10 is going

Rank:
Click to get the best stock tips daily for free!

About Atreca Inc.

Atreca. Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-101 product candidate reacts in vitro with a majority of human ovarian, non-small cell lung, colorectal, ... BCEL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT